Table 2: Novel adipokine concentrations.

VariableControls ( )MetS ( ) value
MetS versus control

hsCRP (mg/L)1.3 (0.5, 4.0)3.1 (1.6, 5.4)0.006
HOMA-IR1.1 (1.0, 2.8)2.8 (1.9, 5.1)0.0001
Plasma chemerin (ng/mL)271 ± 53366 ± 64<0.0001
*(0.0005)
SAT chemerin (ng/mg protein) 3.05 ± 0.943.94 ± 0.74 0.001
Plasma omentin (ng/mL)27 ± 1416 ± 50.004
*(0.03)
SAT omentin (ng/mg protein) 0.31 ± 0.090.22 ± 0.10 0.01
Plasma resistin (ng/mL)1.8 (1.5, 2.5)2.4 (1.7, 3.1)0.04
*(0.07)
SAT resistin (ng/mg protein)0.16 ± 0.060.17 ± 0.05 NS
Plasma visfatin (ng/mL)0.57 (0.38, 0.71)0.59 (0.31, 0.96)0.14
*(0.13)
SAT visfatin (ng/mg protein) 0.17 ± 0.090.21 ± 0.1 NS

 *( value adjusted for age and BMI).
Results are presented as mean ± standard deviation or median (25th percentile and 75th percentile).